Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1998-7-20
pubmed:abstractText
Using nucleolar organizer regions (NORs) as a proliferative marker and Bax expression as a marker for apoptosis, we have studied the individual and combined prognostic significance of these markers. Successive sections of diagnostic, formalin-fixed and paraffin-embedded specimens from 69 patients with T1-4 tumours were stained with a rabbit anti-human Bax polyclonal antibody and silver nitrate for visualization of NORs (AgNORs). After classification for staining intensity and the percentage of Bax expression, a final score resulting in four classes of increasing Bax expression was obtained. AgNOR counts were expressed as mean counts (mAgNOR) and the percentage of tumour nuclei with more than one AgNOR (pAgNOR>1). Both AgNOR parameters were grouped in three classes with increasing values. Low Bax scores correlated significantly with poor prognosis (P = 0.0106). For mAgNOR and pAgNOR>1, high values correlated with poor prognosis (P = 0.0185 and P = 0.0003 respectively). A combined parameter, for which the Bax score was subtracted from the AgNOR scores, appeared to be statistically stronger than the individual parameters (P < 0.0001). Both Bax expression and AgNOR scores, and in particular the combination of these parameters, appear to be strong prognostic markers in glottic squamous cell carcinomas.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-1312892, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-1335841, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-1370566, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-1596315, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-1690415, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-1707972, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-1716455, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-2202342, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-2231191, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-2423479, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-2986519, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-4718080, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-6179954, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-7515669, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-7634826, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-7671262, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8105046, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8187588, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8294493, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8358790, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8432202, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8432516, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8552390, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8608975, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8620501, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8647960, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8649796, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8690508, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-8690514, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-9030940, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-9166951, http://linkedlifedata.com/resource/pubmed/commentcorrection/9662258-9179068
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
100-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas.
pubmed:affiliation
Department of Otolaryngology, The National Hospital, Rikshospitalet, University of Oslo, Norway.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't